Published by Abigail Townsend on 24th January 2023
(Sharecast News) - Johnson & Johnson increased its full-year earnings guidance on Tuesday, helped by strong demand for its cancer drugs.
URL: http://www.digitallook.com/dl/news/story/33256511/...